Why choose Olink for targeted protein biomarker discovery?
We are impressed by the quality of data delivered by the Olink technology with very small sample sizes. The application in the field of precision medicine is extremely promising.Professor Mathias Uhlen, Science for Life Laboratory & Royal Institute of Technology (KTH), Stockholm
Olink's Immunoassay panels are very useful tools for targeting and discovering protein dynamics in our longitudinal studies, such as the integrative personal omics profile (iPOP).Professor Mike Snyder, Department of Genetics, Stanford University
The Olink panel provided some directions we wouldn’t have considered previously, and is a very appealing strategy for neuroscience projects hoping to identify novel CSF biomarkers.Tom Lanz, Principal Scientist, Pfizer Neuroscience
It is critical that scientists have a proteomics service that is based on reliable analytical systems, provides effective data management and delivers expert post-analysis technical support. I am happy to say that Olink Proteomics emphatically delivers all these elements.Dr John Taylor, Centre for Oral Health Research, Newcastle University, UK
News & Events Highlights
Olink’s compliance with new EU personal data protection law
Olink Proteomics aims to be fully compliant with the new European Union General Data Protection Regulation (GDPR), which comes into force on May 25, 2018. Consequently, we have now published a comprehensive Integrity Policy that details how we collect, process, store, protect and remove personal data through our various channels and activities.